Johnson & Johnson offered added details on Friday in regard to its two most recent recalls of Tylenol and other over-the-counter drugs, stating about the actions on Thursday and June 15 that it involved a total of around 3 million bottles of the medicines.
The firm made an announcement of the most recent recall on Thursday, involving 21 lots of medications as well Tylenol for kids and adults, a variety of Benadryl allergy tablets and painkiller Motrin. But it did not reveal the number of affected bottles.
A Company Spokesperson said on Friday, following media condemnation concerning the shortage of information, said the firm shipped just about 2.5 million bottles of the affected lots, which were caught in yesterday's recalls.
The corporation recalled four batches of Benadryl and one batch of Extra Strength Tylenol gels on June 15, also without testifying the number of bottles that were concerned. On Friday, it said that recall arrived at a total of 500,000 bottles.
Both recalls were linked with the company's Jan. 15 recall of 53 million bottles of extensively used products, J&J said.
They were all associated with problems of odors that had been traced to a chemical in pallets used to transport and stock up the medicines.
Related News
- Johnson & Johnson recalls more medicines
- J&J Sales Plunge after Drug Recall Announcement
- Johnson & Johnson Recalls Eprex
- Molson Coors Recalls its Mislabeled Beer Bottles in Quebec
- Johnson & Johnson to recall 13 million packages of Rolaids product
- J&J to Reduce Daily Dosage of Acetaminophen from Eight to Six Pills
- Baby Lotion of Johnson & Johnson Recalled
